Skip to main content
Figure 4 | Radiation Oncology

Figure 4

From: Prospective longitudinal assessment of parotid gland function using dynamic quantitative pertechnate scintigraphy and estimation of dose–response relationship of parotid-sparing radiotherapy in head-neck cancers

Figure 4

Fitted dose–response curves for normal tissue complication probability of severe xerostomia (defined as SEF ratio <45%) as a function of mean parotid dose at 3-months (a), 12-months (b), 24-months (c), and 36-months (d) respectively. Upper and lower curves represent 95% confidence intervals for the fitted model.

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us